Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Dr Reddy's Laboratories Ltd

+ Add to Watchlist

DRRD:IN

3,415.40 INR 30.30 0.88%

As of 07:05:48 ET on 03/27/2015.

Snapshot for Dr Reddy's Laboratories Ltd (DRRD)

Open: 3,434.90 Day's Range: 3,360.20 - 3,434.90 Volume: 263,375
Previous Close: 3,445.70 52wk Range: 2,246.50 - 3,666.25 1-Yr Rtn: +30.94%

Stock Chart for DRRD

No chart data available.
  • DRRD:IN 3,415.40
  • 1D
  • 1M
  • 1Y
3,445.70
Interactive DRRD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRRD

Current P/E Ratio (ttm) 26.9949
Estimated P/E(03/2015) 25.4268
Relative P/E vs. SENSEX 1.4156
Earnings Per Share (INR) (ttm) 126.5200
Est. EPS (INR) (03/2015) 134.3230
Est. PEG Ratio 1.5775
Market Cap (M INR) 581,668.68
Shares Outstanding (M) 170.31
30 Day Average Volume 309,258
Price/Book (mrq) 6.3985
Price/Sale (ttm) 4.3941
Dividend Indicated Gross Yield 0.53%
Cash Dividend (INR) 18.0000
Dividend Ex-Date 07/11/2014
5 Year Dividend Growth 23.56%
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRRD

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for DRRD

Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.

G V PrasadCo-Chair/CEO/Mng DirSaumen ChakrabortyPresident/CFO
Abhijit MukherjeeChief Operating OfficerSripada ChandrasekharPres & Global Head:Human Resources
More Company Profile & Key Executives for DRRD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil